| Kathleen Taylor, RN | |
|
818 Riverside Avenue, Adrian, MI 49221 | |
| (517) 265-0429 | |
| Not Available |
| Full Name | Kathleen Taylor |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 818 Riverside Avenue, Adrian, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427059658 | NPI | - | NPPES |
| 0784512 | Medicaid | OH | |
| 200115050 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 208944 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Taylor, RN P.o. Box 460, Maineville, OH 45039 Ph: (517) 265-0429 | Kathleen Taylor, RN 818 Riverside Avenue, Adrian, MI 49221 Ph: (517) 265-0429 |
News Archive
Cancer of the pancreas is the number five in the list of deaths due to cancers in Spain and the third causing deaths due to digestive tumour.
OTC Stock Review announces that it has initiated coverage of Assured Pharmacy, Inc. Assured Pharmacy, a growing chain of specialty pharmacies specializing in servicing patients who live with chronic pain, just reported a 20.8 percent increase in same store sales for June 2010 versus June 2009.
Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors - yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment.
In anticipation of World Tuberculosis (TB) Day, commemorated on March 24, this Lancet editorial examines TB control and elimination efforts in 2012 and beyond. "Tuberculosis killed 1.45 million people in 2010 and about 500,000 people have drug-resistant disease," the editorial states, adding, "Despite a woeful funding gap in 2012 of $1.7 billion, tuberculosis incidence is falling (from 9.4 million in 2009 to 8.8 million in 2010)."
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces the risk of advanced fibrosis in those with nonalcoholic fatty liver disease (NAFLD).
› Verified 2 days ago
Mr. Walter Vincent Hamilton Iii, MSN;CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 818 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0900 |